ClinicalTrials.gg
Enrolling by invitationNCT06669741Updated May 8, 2025

Clinical Outcomes Related to Arthroscopic Rotator Cuff Repair Recovery Using Incrediwear

An interventional study of Placebo and Shoulder Sleeve in Rotator Cuff Tears, Rotator Cuff Injuries and Rotator Cuff Arthropathy of Left Shoulder (Disorder), sponsored by Texas Bone and Joint. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-08.

Sponsored by Texas Bone and Joint · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 168 studies in Rotator Cuff Injuries with a site in United States — 40 open to participants now, 50 under way, none of them phase 3. Rotator Cuff Injuries · United States.

Planned enrollment
22nd of 130
140 · median 60
Started
2024
with 10 others
No phase
86 of 168
21 open now
Primary completion
2026-12
later than 14 of 49 live
Registered
152nd of 168
by date

Among the 168 studies in Rotator Cuff Injuries with a site in United States, this one is the 22nd largest by planned enrollment of the 130 interventional ones that give a count, is one of 11 that started in 2024, is one of 86 with no phase, reaches primary completion later than 14 of the 49 other live ones, and was the 152nd registered.

Rotator Cuff Injuries

632 studies on the registry are indexed under Rotator Cuff Injuries; 157 are open to participants now.

Browse Rotator Cuff Injuries studies →

Open to participants now

40 of the 168 studies in Rotator Cuff Injuries with a site in United States are open now. Recruiting first, the newest first:

35 more — sign in →

All 40 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 100 Rotator Cuff Injuries studies recruiting now, 40 (40%) set no upper age limit and 41 (41%) stop at 75 or younger; 9 take children under 18; 10 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 168 studies in Rotator Cuff Injuries with a site in United States, or all of them as a file.
02

Study summary

To assess the benefits of using the Incrediwear products for patients recovering from Arthroscopic Rotator Cuff Repair surgery for postoperative pain, range of motion, and swelling.

Read the detailed description

Study Screening/pre-operative appointment

  • The surgeon confirms the participant meets the inclusion criteria and is scheduled for surgery in the next few weeks.
  • The surgeon will discuss the study and possible risks/benefits of being in the research.
  • The study team will measure the participant wrist, arm, and shoulder circumference.
  • The participant will rate their shoulder pain on a 1-10 Visual Analog Scale (VAS); shoulder function with the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire; shoulder function with the American Shoulder and Elbow Surgeons Score (ASES) scale, and function limitations using the Western Ontario Rotator Cuff Index (WORC) questionnaire.
  • The study team will measure the patient's shoulder's range of motion, stability, and strength.
  • Radiographic assessments may be analyzed if already indicated for patient care and included in standard of care procedure.

    • Day of Surgery
  • A study packet will be given to the participant by the study staff. The packet will include a study number assignment, the products assigned, and the patient study journal. The participant, surgeon, and clinical staff will not know which group the participant is in.
  • After surgery, the surgeon and PI, Dr. Flowers, will place the shoulder brace and arm sleeve according to the random assignment in the study packet. An abduction sling will then be placed on top of the shoulder brace and arm sleeve by Dr. Flowers.
  • Participant will be instructed to wear the shoulder brace and arm sleeve for at least 20 hours per day, including overnight, for 12 weeks post-surgery.
  • Participant will be instructed on the length of time to wear the shoulder abduction sling by the surgeon.
  • The clinical staff will take arm circumference measurements post-surgery.

    • Postoperative Recovery: Weeks 1-12
  • Follow-up visits will be at 2 weeks, 6 weeks, and 12 weeks post-surgery. During follow-up visits:

    • The clinical staff will take arm swelling measurements.
    • Participant shoulder pain on a 1-10 Visual Analog Scale (VAS); shoulder function with the Disabilities of the Arm, Shoulder, and Hand (DASH), American Shoulder and Elbow Surgeons score (ASES), and Western Ontario Rotator Cuff Index (WORC) questionnaires.
    • The clinical staff will measure shoulder's range of motion, stability, and strength.
    • Radiographic assessments may be analyzed if already indicated for patient care and included in standard of care procedure.
  • Daily reported measures include:

    • Participant will record pain medication type and quantity taken in a medications log. Only medications related to the treatment of shoulder pain or function will be required to be reported.
    • Participant will rate shoulder pain severity on a 1-10 VAS in a pain diary log.
    • Participant will record how long they have worn the shoulder brace and arm sleeve in device usage log.
  • At the 12th week follow-up visit all study products, including the shoulder brace, arm sleeve, medications log, pain diary log, and device usage log.

    • Postoperative Recovery: 6 months and 1 year post surgery
  • A follow-up phone call after 6 months and 1-year post-surgery will be administered.
  • Participant will be asked to rate shoulder pain on a 1-10 Visual Analog Scale (VAS) and shoulder function with the Disabilities of the Arm, Shoulder, and Hand (DASH), American Shoulder and Elbow Surgeons score (ASES), and Western Ontario Rotator Cuff Index (WORC) questionnaires.
03

Conditions studied

  • Rotator Cuff Tears
  • Rotator Cuff Injuries
  • Rotator Cuff Arthropathy of Left Shoulder (Disorder)
  • Rotator Cuff Arthropathy of Right Shoulder (Disorder)
  • Rotator Cuff Arthropathy of Bilateral Shoulders

Browse trials for

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients undergoing arthroscopic rotator cuff repair
  2. Patients aged 18-75
  3. Patients who are willing and able to adhere to follow-up schedule and protocol guidelines.
  4. Patients who are willing and able to sign corresponding research subject consent form.

Exclusion criteria

Exclusion Criteria:

  1. Patient has a history of neurological conditions, including multiple sclerosis or Parkinson's disease
  2. Patient has severe medical condition, including recent myocardial infarction, unstable angina, heart failure, severe anemia
  3. Patient has had prior surgical treatment of a shoulder injury in the past 5 years
  4. Patient has chronic pain conditions unrelated to shoulder condition
  5. Patient has auto-immune or auto-inflammatory diseases
  6. Patient has used tobacco within the last 90 days
  7. Patient is not within the ages of 18-75
  8. Patient has poorly controlled diabetes with HgA1c > 7.5
  9. Patient has an active infection (local or systemic)
  10. Patient is unwilling or unable to sign the corresponding research subject consent form
  11. Patient meets any other criteria or has any other condition that, in the opinion of the investigator, would prevent them from completing the study or that, in the opinion of the investigator, would confound study results.
  12. Against medical advice (AMA)
  13. Prisoner as indicated in the medical record
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
140 participants (estimated)

Study arms

  • Placebo comparator
    Placebo

    To assess the benefits of using the Incrediwear (Shoulder Sleeve) products for patients recovering from Arthroscopic Rotator Cuff Repair surgery for postoperative pain, range of motion, and swelling. We will compare patients with Incrediwear products or placebo Incrediwear products throughout a 12-week period with follow-ups up to 1-year post-surgery. The study will be double blinded as to the active Incrediwear sleeve vs placebo.

    Device: Placebo

  • Active comparator
    Incrediwear Product

    To assess the benefits of using the Incrediwear (Shoulder Sleeve) products for patients recovering from Arthroscopic Rotator Cuff Repair surgery for postoperative pain, range of motion, and swelling. We will compare patients with Incrediwear products or placebo Incrediwear products throughout a 12-week period with follow-ups up to 1-year post-surgery. The study will be double blinded as to the active Incrediwear sleeve vs placebo.

    Device: Shoulder Sleeve

Interventions

  • DevicePlacebo

    One group will receive placebo therapy (identical shoulder brace and arm sleeve absent of semiconductor fabric)

  • DeviceShoulder Sleeve

    One group will receive active therapy (active semiconductor embedded shoulder brace and arm sleeve)

06

What researchers measure

Primary outcomes

  1. Arm Circumference Measure with a Measuring tape

    To measure swelling in the upper arm, a soft tape measure to measure the circumference of the arm at multiple points at the writs, mid-forearm, axilla, and oblique. A 2cm difference between arms at each area of the wrist, mid-forearm, axilla, and oblique shoulder is not optimal. Less than 2cm difference between arms at each area of the wrist, mid-forearm, axilla, and oblique shoulder is optimal.

    Time frame: Preop appointment, Postop Day 42, Day 84, Day 168, Day 364

Secondary outcomes

  1. Visual Analogue Scale Measured by Scale

    The pain VAS is a unidimensional measure of pain intensity, used to record patients' pain progression, or compare pain severity between patients with similar conditions. The minimum number is zero meaning no pain and maximum number is 10 meaning the most pain the patient has every felt in their entire life. Lower scores are ideal while higher scores are indicative of the patient in a lot of pain.

    Time frame: Preop appointment, Postop Day 42, Day 84, Day 168, Day 364

  2. Range of Motion Measured by a Goniometer

    To measure the range of motion of the shoulder, the patient will: Flexion: Move the arm forward and up until it's above the head. Extension: Move the arm backward. Abduction: Move the arm away from the body until it's above the head. Adduction: Move the arm toward the body. External rotation: With the elbow bent at a 90° angle, move the forearm away from the body. Internal rotation: With the elbow bent at a 90° angle, move the forearm toward the body. Shoulder flexion 0-180 degrees normal range Shoulder extension 0-60 degrees normal range Shoulder abduction 0-180 degrees normal range Shoulder adduction 180-0 degrees normal range Shoulder external rotation 0-90 degrees normal range Shoulder internal rotation 0-70 degrees normal range ...with lower number being poor and higher number being optimal

    Time frame: Preop appointment, Postop Day 42, Day 84, Day 168, Day 364

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided — Pre-approval to share data and data results must be obtained by the corporation.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2024 (actual). Primary completion is estimated for Dec 2026, 24 months after the start.

Of 228 non-industry interventional studies with no phase under Rotator Cuff Injuries, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 39. This study's planned 24 months is above that.

Counting every sponsor, half of 252 studies reached it within 23 months; a quarter within 11 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 30, 2024
First posted
Nov 1, 2024
StartActual
Nov 11, 2024
Primary completionEst.
Dec 1, 2026
CompletionEst.
Dec 2, 2026
Last update
May 8, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06669741
Lead sponsor
Texas Bone and Joint
Collaborators
INCREDIWEAR HOLDINGS, INC.
Responsible party
Christopher Flowers, MD (Orthopaedic Surgeon, Texas Bone and Joint) — Principal investigator
First posted
Nov 1, 2024
Start date
Nov 11, 2024
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 2, 2026 (estimated)
Last update
May 8, 2025

Study contacts

Christopher L. Flowers
principal investigator · Texas Bone and Joint

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion